Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$2.46M Sell
32,888
-73
-0.2% -$5.2K 0.24% 138
2022
Q3
$2.13M Buy
32,961
+3,306
+11% +$229K 0.26% 101
2022
Q2
$2.06M Buy
29,655
+3,564
+14% +$265K 0.23% 127
2022
Q1
$2M Buy
26,091
+7,021
+37% +$505K 0.2% 153
2021
Q4
$1.46M Hold
19,070
0.14% 250
2021
Q3
$1.41M Sell
19,070
-194
-1% -$14.5K 0.14% 253
2021
Q2
$1.28M Buy
19,264
+86
+0.4% +$5.75K 0.12% 266
2021
Q1
$1.43M Buy
19,178
+2,214
+13% +$168K 0.14% 233
2020
Q4
$1.24M Sell
16,964
-96
-0.6% -$6.78K 0.13% 264
2020
Q3
$1.13M Buy
17,060
+3,227
+23% +$204K 0.12% 251
2020
Q2
$788K Sell
13,833
-2,994
-18% -$147K 0.09% 322
2020
Q1
$530K Sell
16,827
-129
-0.8% -$6.14K 0.07% 367
2019
Q4
$885K Hold
16,956
0.09% 352
2019
Q3
$856K Hold
16,956
0.09% 350
2019
Q2
$814K Sell
16,956
-3,710
-18% -$172K 0.08% 369
2019
Q1
$1M Sell
20,666
-8,695
-30% -$392K 0.1% 319
2018
Q4
$1.21M Buy
+29,361
New +$1.2M 0.17% 184

Other funds holding HOLX

Seeyond's HOLX Position: Q4 2022 in Review

Seeyond reduced its Hologic (HOLX) stake by 0.22% in Q4 2022, selling an estimated $5.2K and leaving 32,888 shares worth $2.46M. The position accounts for 0.24% of the portfolio, ranked #138.

Seeyond first reported a position in HOLX in Q4 2018 and has held it in 17 quarters since. 697 funds tracked by Wall St. Rank hold HOLX as of Q4 2022.

  • Seeyond held 32,888 shares of Hologic worth $2.46M as of Q4 2022.
  • Seeyond sold 73 Hologic shares in Q4 2022, an estimated $5.2K.
  • Hologic made up 0.24% of Seeyond's portfolio in Q4 2022, its #138 holding.
  • Seeyond first reported a position in Hologic in Q4 2018 and has held it in 17 quarters since.
  • 697 funds tracked by Wall St. Rank held Hologic as of Q4 2022.

Based on Seeyond's 13F filing for Q4 2022, filed 13 Feb 2023.